Alpha Teknova, Inc. (TKNO) Stock Grade

About Alpha Teknova, Inc.'s fundamentals

Alpha Teknova is a specialty and generic drug manufacturer with a market capitalization of $493.2 million that generated 7.4% year-over-year revenue growth in its latest reporting period. However, the company is currently unprofitable, reporting a net loss with a net margin of -42.6%, and does not pay a dividend to shareholders. The company's inability to achieve profitability despite revenue growth suggests ongoing challenges in managing costs relative to sales, which is a notable concern for investors evaluating its financial health.